Global Neurofeedback Therapy Device Market Growth 2025-2031

The global Neurofeedback Therapy Device market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Neurofeedback is a non-invasive method of monitoring and training your brain waves through electronic equipment (typically EEG devices) in order to evaluate your mind and body. Neurofeedback therapy helps you become a more well-rounded person equipped to tackle adversity as well as enhances your mental fitness so you can enjoy a balanced life and healthy relationships. Neurofeedback equipment plays a key role in optimizing your mental fitness.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “Neurofeedback Therapy Device Industry Forecast” looks at past sales and reviews total world Neurofeedback Therapy Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Neurofeedback Therapy Device sales for 2025 through 2031. With Neurofeedback Therapy Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurofeedback Therapy Device industry.

This Insight Report provides a comprehensive analysis of the global Neurofeedback Therapy Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurofeedback Therapy Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurofeedback Therapy Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurofeedback Therapy Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurofeedback Therapy Device.

This report presents a comprehensive overview, market shares, and growth opportunities of Neurofeedback Therapy Device market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

Electroencephalogram (EEG) Machines

Functional Magnetic Resonance Imaging (FMRI) Machines

Hemoencephalography (HEG) Devices

Segmentation by Application:

Home

Professional Clinic

Hospital

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Interaxon

BrainMaster

Narbis

Neurosky

Sens.ai

Neurotech

Mendi

NeurOptimal

ANT Neuro

Neurogen

EEG Info

FocusCalm

NeuroSky

Thought Technology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Neurofeedback Therapy Device market?

What factors are driving Neurofeedback Therapy Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Neurofeedback Therapy Device market opportunities vary by end market size?

How does Neurofeedback Therapy Device break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.